Ovarian Cancer Trial, Recruiting NCT07394530 Sponsor: Hanoi General Hospital (Vietnam) Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07394530
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women between 18 and 40 years of age
  • People who have been diagnosed with polycystic ovary syndrome (PCOS) based on specific diagnostic criteria (known as the modified Rotterdam criteria), meaning a doctor has confirmed at least 2 of the following 3 features: irregular or absent ovulation, higher-than-normal male hormone levels, or a specific appearance of the ovaries on ultrasound
  • People whose doctor has recommended IVF (in vitro fertilization) because of PCOS alone, or PCOS combined with other fertility-related factors such as blocked fallopian tubes or previous unsuccessful fertility treatment (IUI)
  • People who have been assessed as suitable for ovarian stimulation as part of IVF treatment
  • People whose husband or partner has either normal sperm results, or mildly to moderately reduced sperm quality or quantity
  • People who are willing and able to sign a consent form and follow the study procedures throughout the trial

Who may not be able to join:

  • People who have structural problems with the uterus that could affect pregnancy, such as uterine shape abnormalities present from birth, large fibroids that change the shape of the uterine cavity, adenomyosis, or other significant uterine conditions
  • People who have had major surgery on the ovaries or uterus that may have affected ovarian function or uterine structure — for example, surgery to remove ovarian cysts, endometriosis surgery, fibroid removal, or removal of one ovary
  • People who have had 3 or more miscarriages
  • People, or their partner, who have a known chromosomal (genetic) abnormality
  • People who would be unable to follow the trial schedule or attend required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Phuong Duy Nguyen, MD, MS, Hanoi General Hospital

Phone: +84 986656835

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Hanoi General Hospital (Vietnam)
Registry
ClinicalTrials.gov
Start date
20 January 2026
Est. completion
30 June 2027

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

Ongoing pregnancy rate at 12 weeks

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov